Antimicrobial susceptibility of Staphylococcus spp. isolated from dogs with pyoderma

• Autorzy: Siugzdaite J. , Zamokas G. , Grigonis A. , Macijauskas V. , Lasys V.
• Języki publikacji: EN

Abstrakty

EN

The aim of this study was to evaluate antimicrobic resistance in canine staphylococci to the major classes of antimicrobials used in veterinary dermatology. The data was collected in 2002-2006 in the Dr L. Kriauceliunas small animal clinic of the Lithuanian Veterinary Academy. Clinical evaluation of 163 dogs was performed together with microscopical, mycological and bacteriological examinations. The clinical evaluation included the age of the dog, breed, sex, hair structure and season of the year. The authors found out that during the 5 year period males got the disease more often than females (52.98% versus 42.02%) and dogs at the ages of 1-5 years were the most common patients (43.9%). Bacterial skin diseases were more common in short-haired dogs (61.81%, p < 0.05). Long-haired dogs were more likely to be affected by bacterial skin diseases in the cold season (p < 0.05). Bacteriological examination revealed that the most common cause of bacterial skin infections was Staphylococcus intermedius (71.76%, p < 0.05) and Staphylococcus aureus (23.68%, p < 0.05). Mixed cultures (Staphylococcus spp., Streptococcus spp., Pseudomonas spp. and Escherichia coli) were found to be the cause of 4.56% (p < 0.05) of all bacterial skin diseases. S. intermedius and S. aureus strains exhibited the best sensitivity to ciprofloxacin, amikacin, methicillin (100%) and to cephadroxil (respectively 91.75% and 100%). S. intermedius strains were most resistant to sulphanilamides/trimethoprim (82.28%), S. aureus - to amoxicillin (86.0%).

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2008
• Tom: 64
• Numer: 08
• Opis fizyczny: p.991-994,ref.

Twórcy

autor

Siugzdaite J.

• Lithuanian Veterinary Academy, Tilzes g. 18, LT-47181 Kaunas, Lithuania

autor

Zamokas G.

autor

Grigonis A.

autor

Macijauskas V.

autor

Lasys V.

Bibliografia

• 1.Bauer A. W., Kirby W. M. M., Sherris W. M. M., Turck M.: Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1966, 45, 493-496.
• 2.Breathnach R. M., Baker K. P., Quinn P. J., Mcgeady T. A., Aherne C. M., Jones B. R.: Clinical, immunological and histopathological findings in a subpopulation of dogs with pododermatitis. Vet. Dermatol. 2005, 16, 364-372.
• 3.Campbell K. L.: Sulphonamides: updates on use in veterinary medicine. Vet. Dermatol. 1999, 10, 205-215.
• 4.Curtis C. F., Lamport A. I., Lloyd D. H.: Masked, controlled study to investigate the efficacy of a Staphylococcus intermedius autogenous bacterin for the control of canine idiopathic recurrent superficial pyoderma. Europ. Soc. Vet. Dermatol. 2006, 17, 163-168.
• 5.Harvey R. G., Hunter P. A.: The properties and use of penicillins in the veterinary field, with special reference to skin infections in dogs and cats. Vet. Dermatol. 1999, 10, 177-186.
• 6.Holm B. R., Petersson U., Mörner A., Bergström K., Franklin A., Greko C.: Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden. Vet. Rec. 2002, 151, 600-605.
• 7.Holm B. R., Rest J. R., Seewald W.: A prospective study of the clinical findings, treatment and histopathology of 44 cases of pyotraumatic dermatitis. Vet. Dermatol. 2004, 15, 369-376.
• 8.Ihrke P. J., Papich M. G., Demanuelle T. C.: The use of fluoroquinolones in veterinary dermatology. Vet. Dermatol. 1999, 10, 193-204.
• 9.Forsythe P. J., Hill P. B., Thoday K. L., Brown J.: Use of computerized image analysis to quantify staphylococcal adhesion to canine corneocytes: does breed and body site have any relevance to the pathogenesis of pyoderma? Vet. Dermatol. 2002, 13, 29-36.
• 10.Kim T. J., Na Y. R., Lee J. I.: Investigations into the basis of chloramphenicol and tetracycline resistance in Staphylococcus intermedius isolates from cases of pyoderma in dogs. J. Vet. Med. 2005, B 52, 119-124.
• 11.Mason I. S., Lloyd D. H.: Scanning electron microscopical studies of the living epidermis and stratum corneum in dogs, [in:] Ihrke P. J., Mason I. S., White S. D. (eds): Advances in Veterinary Dermatology. Vol. 2. Oxford: Pergamon Press 1993, 131-139.
• 12.Morris D. O., Rook K. A., Shofer F. S., Rankin S. C.: Screening of Staphylococcus aureus, Staphylococcus intermedius and Staphylococcus schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-2004). Europ. Soc.Vet. Dermatol. 2006, 17, 332-337.
• 13.NCCLS. Performance standards for antimicrobial susceptibility testing: twelfth informational supplement (M100-S17). National Committee for clinical laboratory standards. Wayne, P.A. 2007.
• 14.Noble W. C., Kent L. E.: Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog. Vet. Dermatol. 1992, 3, 71-74.
• 15.Noli Ch., Boothe D.: Macrolides and lincosamides. Vet. Dermatol. 1999, 10, 217-223.
• 16.Paradis M., Abbey L., Baker B., Coyne M., Hannigan M., Joffe D., Pukay B., Triettien A., Waisglass S., Wellington J.: Evaluation of the clinical efficacy of marbofloxacin (Zenequin) tablets for the treatment of canine pyoderma: an open clinical trial. Vet. Dermatol. 2001, 12, 163-169.
• 17.Rantala M., Lahti E., Kuhalampi J., Pesonen S., Järvinen A.-K., Saijonmaa-Koulumies L., Honkanen-Buzalski T.: Antimicrobial resistance in Staphylococcus spp., Escherichia coli and Enterococcus spp. In dogs given antibiotics for chronic dermatological disorders, compared with non-treated control dogs. Acta Vet. Scand. 2004, 45, 37-45.
• 18.Saijonmaa-Koulumies L. E. M., Lloyd D. H.: Adherence of Staphylococcus intermedius to canine corneocytes in vitro. Vet. Dermatol. 2002, 13, 169-176.
• 19.Schwarz S., Noble W. C.: Aspects of bacterial resistance to antimicrobials used in veterinary dermatological practice. Vet. Dermatol. 1999, 10, 163-176.
• 20.Scott D. W., Peters J., Miller W. H. Jr.: Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs. Canad. Vet. J. 2006, 47, 999-1002.
• 21.Sentürk S., Özel E., Sen A.: Clinical Efficacy of Rifampicin for Treatment of Canine Pyoderma. Acta Vet. Brno 2005, 74, 117-122.
• 22.Simou Ch., Thoday K. L., Forsythe P. J., Hill P. B.: Adherence of Staphylococcus intermedius to corneocytes of healthy and atopic dogs: effect of pyoderma, pruritus score, treatment and gender. Vet. Dermatol. 2005, 16, 385-391.
• 23.Šeol B.: Comparative in vitro activities of enrofloxacin, ciprofloxacin and marbofloxacin against Staphylococcus intermedius isolated from dogs. Veterinarski Arhiv 2005, 75, 189-194.
• 24.Vandenesch F., Naimi T., Enright M. C., Gerard L., Nimmo G. R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M. E., Etienne J.: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg. Infect. Dis. 2003, 9, 978-984.
• 25.Werckenthin C., Cardoso M., Martel J. L., Schwarz S.: Antimicrobial resistance in staphylococci from animals with particular reference to bovine S. aureus, porcine S. hyicus and canine S. intermedius. Vet. Res. 2001, 32, 341-362.

Uwagi

Rekord w opracowaniu